We are an international company based in Parma, with 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.
With a turnover of more than €1.571 billion sales we are among the top 50 pharmaceutical companies in the world. Our production sites are in Parma, Italy, Blois (France) and Santana De Parnaiba (Brazil).
Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK) and the R&D team from the newly-acquired Danish company Zymenex, integrate their efforts to advance Chiesi’s pre-clinical, clinical and registration programmes.
We export to more than 70 countries with a direct presence in 26.
The Chiesi Group employs approximately 4,813 people, 671 of whom are dedicated to R&D activities and 700 of whom work at production sites in Italy, France and Brazil.
